Webinar Series: Predictive Assays and Clinically-Relevant Biomarkers for Parkinson’s Disease Drug Discovery
Neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) represent an ever-increasing unmet medical need.
In two-part webinar series, we showcase in vitro phenotypic assays to identify new disease targets and novel drug compounds and highlight the development of biomarkers for disease modifying and symptom management therapies in in vivo models.
